ScholarMate
English简体中文繁體中文
客服热线:400-1616-289
登录注册
期刊论文

A Robust Metabolic Enzyme-Based Prognostic Signature for Head and Neck Squamous Cell Carcinoma

Mai, Zizhao; Chen, Huan; Huang, Mingshu; Zhao, Xinyuan*; Cui, Li*南方医科大学
Frontiers in Oncology2022-1-20DOI: 10.3389/fonc.2021.770241
2被引12阅读
引用收藏
分享

摘要

BackgroundHead and neck squamous cell carcinoma (HNSCC) is still a menace to public wellbeing globally. However, the underlying molecular events influencing the carcinogenesis and prognosis of HNSCC are poorly known. MethodsGene expression profiles of The Cancer Genome Atlas (TCGA) HNSCC dataset and GSE37991 were downloaded from the TCGA database and gene expression omnibus, respectively. The common differentially expressed metabolic enzymes (DEMEs) between HNSCC tissues and normal controls were screened out. Then a DEME-based molecular signature and a clinically practical nomogram model were constructed and validated. ResultsA total of 23 commonly upregulated and 9 commonly downregulated DEMEs were identified in TCGA HNSCC and GSE37991. Gene ontology analyses of the common DEMEs revealed that alpha-amino acid metabolic process, glycosyl compound metabolic process, and cellular amino acid metabolic process were enriched. Based on the TCGA HNSCC cohort, we have built up a robust DEME-based prognostic signature including HPRT1, PLOD2, ASNS, TXNRD1, CYP27B1, and FUT6 for predicting the clinical outcome of HNSCC. Furthermore, this prognosis signature was successfully validated in another independent cohort GSE65858. Moreover, a potent prognostic signature-based nomogram model was constructed to provide personalized therapeutic guidance for treating HNSCC. In vitro experiment revealed that the knockdown of TXNRD1 suppressed malignant activities of HNSCC cells. ConclusionOur study has successfully developed a robust DEME-based signature for predicting the prognosis of HNSCC. Moreover, the nomogram model might provide useful guidance for the precision treatment of HNSCC.

学科与关键词

关键词
head and neck squamous cell carcinoma (HNSCC)metabolic enzymeprognostic signaturesurvival analysisThe Cancer Genome Atlas
相关
加载中…
  • A novel metabolic-related gene signature for predicting clinical prognosis and immune microenvironment in head and neck squamous cell carcinoma
    Cao, Yongxin; Dai, Zili; Xie, Guofeng; Liu, Guihong; Guo, Liyi*; Zhang, Jian*Experimental Cell Research, 2023, 428(2): 113628.
  • Transcriptome analysis reveals the prognostic and immune infiltration characteristics of glycolysis and hypoxia in head and neck squamous cell carcinoma
    Liu, Jun; Lu, Jianjun; Li, Wenli*BMC CANCER, 2022, 22(1): 352.被引 6
  • A novel comprehensive immune-related gene signature as a promising survival predictor for the patients with head and neck squamous cell carcinoma
    Fang, Ruihua; Iqbal, Muhammad; Chen, Lin; Liao, Jing; Luo, Jierong; Wei, Fanqin; Wen, Weiping*; Sun, Wei*Aging-US, 2021, 13(8): 11507-11527.被引 4
查看全部 →

发表信息

论文状态
公开发表
期刊
Frontiers in Oncology
发表日期
2022-01-20
卷期
第 11 卷
页码
770241
DOI
10.3389/fonc.2021.770241
期刊等级
3区
成果收录
SCIE
资助标注
National Natural Science Foundation of China [81901006]; Guangdong Basic and Applied Basic Research Foundation [2020A1515110051]

作者

  • M

    Mai, Zizhao (第一作者)

    southern med univ

  • C

    Chen, Huan

    southern med univ

查看全部 5 位作者收起作者
  • H

    Huang, Mingshu

    southern med univ

  • Z

    Zhao, Xinyuan (通讯)

    southern med univ

  • C

    Cui, Li (通讯)

    southern med univ

登录解锁更多功能

  • 收藏这篇,随时在“我的 · 收藏”找回
  • 认领你的成果,生成推广素材
  • 关注作者获取最新成果
  • 加入项目组、协同写作
注册 / 登录

产品服务

  • 科研之友
  • 创新城
  • 科创云

服务支持

  • 帮助中心
  • 隐私政策
  • 服务条款

联系方式

在线客服:【】
客服热线:400-1616-289
电子邮箱:support@scholarmate.com

关注或下载科研之友

微信二维码
微信公众号
客户端下载二维码
下载客户端
科研成果科研人员科研机构科研动态爱瑞思软件

©2026 深圳市科研之友网络服务有限公司

公安备案图标粤公网安备 44030502000213
粤ICP备 16046710 号粤B2-20110417